Edition:
India

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

6.66USD
23 Feb 2018
Change (% chg)

$-0.13 (-1.91%)
Prev Close
$6.79
Open
$6.86
Day's High
$6.86
Day's Low
$6.47
Volume
127,795
Avg. Vol
24,260
52-wk High
$21.59
52-wk Low
$6.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 5 0.88 4.38 0.00 0.83
Earnings (per share)
Quarter Ending Mar-18 4 -0.65 -0.49 -0.74 -0.88
Quarter Ending Jun-18 4 -0.60 -0.52 -0.74 -1.00
Year Ending Dec-18 5 -2.74 -1.93 -3.84 -2.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -66.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.26%
# of Holders: 36
Total Shares Held: 2,685,723
3 Mo. Net Change: -589,793
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 15
# Reduced Positions: 8
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.